A open label, randomized, controled trial to assess the utility of Pitavastatin for patients with type2 diabetes and obesity in Matsuyama Shimin Hospital.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms POM
- 14 Jan 2014 Planned End Date changed from 30 Jun 2014 to 31 Dec 2014, according to University Hospital Medical Information Network - Japan record.
- 31 May 2013 Planned end date changed from 1 Jun 2013 to 30 Jun 2014 as reported by University Hospital Medical Information Network - Japan.
- 30 Jun 2012 Planned end date (Jun 2013) added as reported by University Hospital Medical Information Network - Japan.